The mathematics of drug dose individualization should be built with random-effects linear models

Francisco J. Diaz; Jose De Leon

doi:10.1097/FTD.0b013e318283e3c6

The mathematics of drug dose individualization should be built with random-effects linear models

Francisco J. Diaz, Jose De Leon

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Original language	English
Pages (from-to)	276-277
Number of pages	2
Journal	Therapeutic Drug Monitoring
Volume	35
Issue number	2
DOIs	https://doi.org/10.1097/FTD.0b013e318283e3c6
State	Published - Apr 2013

Bibliographical note

Funding Information:
Supported by Frontiers: The Heartland Institute for Clinical and Translational Research CTSA UL1TR000001 (awarded to the University of Kansas Medical Center). The authors acknowledge Mrs Rosemary Morrow, at the Department of Biostatistics of the University of Kansas Medical Center, who helped in editing this letter.

Funding

Supported by Frontiers: The Heartland Institute for Clinical and Translational Research CTSA UL1TR000001 (awarded to the University of Kansas Medical Center). The authors acknowledge Mrs Rosemary Morrow, at the Department of Biostatistics of the University of Kansas Medical Center, who helped in editing this letter.

Funders	Funder number
Department of Biostatistics of the University of Kansas Medical Center

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

Access to Document

10.1097/FTD.0b013e318283e3c6

Cite this

@article{03f464c90e7443aba64826634b281096,

title = "The mathematics of drug dose individualization should be built with random-effects linear models",

author = "Diaz, {Francisco J.} and {De Leon}, Jose",

note = "Funding Information: Supported by Frontiers: The Heartland Institute for Clinical and Translational Research CTSA UL1TR000001 (awarded to the University of Kansas Medical Center). The authors acknowledge Mrs Rosemary Morrow, at the Department of Biostatistics of the University of Kansas Medical Center, who helped in editing this letter.",

year = "2013",

month = apr,

doi = "10.1097/FTD.0b013e318283e3c6",

language = "English",

volume = "35",

pages = "276--277",

number = "2",

}

TY - JOUR

T1 - The mathematics of drug dose individualization should be built with random-effects linear models

AU - Diaz, Francisco J.

AU - De Leon, Jose

N1 - Funding Information: Supported by Frontiers: The Heartland Institute for Clinical and Translational Research CTSA UL1TR000001 (awarded to the University of Kansas Medical Center). The authors acknowledge Mrs Rosemary Morrow, at the Department of Biostatistics of the University of Kansas Medical Center, who helped in editing this letter.

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84875177796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875177796&partnerID=8YFLogxK

U2 - 10.1097/FTD.0b013e318283e3c6

DO - 10.1097/FTD.0b013e318283e3c6

M3 - Letter

C2 - 23503456

AN - SCOPUS:84875177796

SN - 0163-4356

VL - 35

SP - 276

EP - 277

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 2

ER -

The mathematics of drug dose individualization should be built with random-effects linear models

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this